Company Name: |
Henan Pumei Jihua Pharmaceutical Technology Co., Ltd.
|
Tel: |
037188900765 18037465274 |
Email: |
enyawanglei@sina.cn |
Products Intro: |
Product Name:tert-butyl 2-(ethoxycarbonyl)ethyl2-cyanoethylcarbamate CAS:266353-22-4 Purity:95% HPLC Package:0.1g;0.25g;0.5g;1g;5g;10g;25g
|
Company Name: |
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
|
Tel: |
021-51816796-820 13611835272 |
Email: |
sales2@sunwaypharm.com |
Products Intro: |
Product Name:ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)amino)propanoate CAS:266353-22-4 Purity:97% Package:0.1g;0.25g;1g;5g;10g;25g;100g;500g
|
Company Name: |
Matrix Scientific
|
Tel: |
803 788-9494 All other calls |
Email: |
sales@matrixscientific.com |
Products Intro: |
Product Name:Ethyl 3-(tert-butoxycarbonyl-(2-cyanoethyl)amino)propanoate CAS:266353-22-4 Purity:97%
|
|
| ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate Basic information |
Product Name: | ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate | Synonyms: | ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate;tert-butyl 2-(ethoxycarbonyl)ethyl2-cyanoethylcarbamate;N-(2-Cyanoethyl)-N-[(1,1-dimethylethoxy)carbonyl]-β-Alanine Ethyl Ester;β-Alanine, N-(2-cyanoethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, ethyl ester | CAS: | 266353-22-4 | MF: | C13H22N2O4 | MW: | 270.32478 | EINECS: | | Product Categories: | | Mol File: | 266353-22-4.mol | ![ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate Structure](CAS/20150408/GIF/266353-22-4.gif) |
| ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate Chemical Properties |
Boiling point | 389.4±35.0 °C(Predicted) | density | 1.077±0.06 g/cm3(Predicted) | pka | -1.74±0.70(Predicted) |
| ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate Usage And Synthesis |
Uses | N-(2-Cyanoethyl)-N-[(1,1-dimethylethoxy)carbonyl]-β-Alanine Ethyl Ester is an intermediate in the synthesis of GNE-781 (D447825), a derivative of a highly advanced, potent and selective bromodomain inhibitor of cyclic adenosine monophosphate response element binding protein (CBP). Inhibition of the bromodomain of the transcriptional regulator CBP/P300 is an especially interesting new therapeutic approach in oncology. |
| ethyl 3-(tert-butoxycarbonyl(2-cyanoethyl)aMino)propanoate Preparation Products And Raw materials |
|